The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis.
Open accessAbstract
The histone demethylase PHF8 has been implicated in multiple pathological disorders, including X-linked mental retardation and tumorigenesis. However, it is not clear how the abundance and function of PHF8 are regulated. Here, we report that PHF8 physically associates with the deubiquitinase USP7. Specifically, we demonstrated that USP7 promotes deubiquitination and stabilization of PHF8, leading to the upregulation of a group of genes, including cyclin A2, that are critical for cell growth and proliferation. The USP7-encoding gene was also transcriptionally regulated by PHF8, via positive feedback. USP7 was overexpressed in breast carcinomas, and the level of expression positively correlated with expression of PHF8 and cyclin A2 and with the histological grade of breast cancer. We showed that USP7 promotes breast carcinogenesis by stabilizing PHF8 and upregulating cyclin A2 and that the interaction between USP7 and PHF8 is augmented during DNA damage. Moreover, USP7-promoted PHF8 stabilization conferred cellular resistance to genotoxic insults and was required for the recruitment of BLM and KU70, which are both essential for DNA double-strand break repair. Our study mechanistically links USP7 to epigenetic regulation and DNA repair. Moreover, these data support the pursuit of USP7 and PHF8 as potential targets for breast cancer intervention, especially in combination with chemo- or radiotherapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“several well-characterized USP7 substrates, including p53 30, PHF8 31, and PLK1 32, are known to be key regulators of cell cycle progression and cellular proliferation—processes fundamental to HSC maintenance.”
From USP7 sustains hematopoietic stem cell homeostasis partially via PU.1 stabilization (2026) · cites this paper as [31]
In the citing paper
“In addition to the transcriptional regulation of cyclin A2, PHF8 interacts with Ku70 and the BLM helicase to facilitate their localization to sites of DSBs.”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Wang et al., 2016
In the citing paper
“The depletion of USP7 from cells has been found to greatly compromise the repair of DSBs by either NHEJ or HR (Wang et al., 2016; An et al., 2017).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Wang et al., 2016
In the citing paper
“Indeed, the recruitment of either protein is impaired in cells following PHF8 or USP7 depletion (Wang et al., 2016).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Wang et al., 2016
In the citing paper
“Indeed, USP7, PHF8 and cyclin A2 were all found to be upregulated in several breast cancers, as well as in colon and rectum cancers, compared to adjacent tissues (Wang et al., 2016).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Wang et al., 2016
In the citing paper
“A strong correlation has also been observed between USP7 and the cell cycle regulatory protein PHF8 (Wang et al., 2016). This correlation was observed in clinical breast cancer samples and increased with histological grade.”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Wang et al., 2016
In the citing paper
“As we discussed in the Cell Cycle Regulation section, USP7 deubiquitinates and stabilizes PHF8, allowing the latter to upregulate gene targets involved in cell cycle progression, including cyclin A2 (Liu et al., 2010; Wang et al., 2016).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Wang et al., 2016
In the citing paper
“USP7 has also been suggested as a potential target for sensitization in breast cancer treatment, where USP7 is frequently upregulated and confers resistance to genotoxic insult, by stabilizing PHF8 (Wang et al., 2016).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Wang et al., 2016
In the citing paper
“USP7 has also been suggested as a potential target for sensitization in breast cancer treatment, where USP7 is frequently upregulated and confers resistance to genotoxic insult, by stabilizing PHF8 (Wang et al., 2016).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Wang et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
The complex language of chromatin regulation during transcription
Berger, S. L. (2007) · Nature · doi:10.1038/nature05915 · Cited by 2,768
Towards a knowledge-based Human Protein Atlas
Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E., Jonasson, K., Forsberg, M., Zwahlen, M., Kampf, C., Wester, K., Hober, S., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt1210-1248 · Cited by 2,440
Rhodes, D. R., Sundaram, S. K., Mahavisno, V., Varambally, R., Yu, J., Briggs, B., Barrette, T. R., Anstett, M. J., Kincead-Beal, C., Kulkarni, P., et al. (2007) · Neoplasia · doi:10.1593/neo.07112 · Cited by 2,057
Breaking the chains: structure and function of the deubiquitinases
Komander, D., Clague, M. J., & Urbé, S. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2731 · Cited by 1,969
53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
Bunting, S. F., Callén, E., Wong, N., Chen, H.-T., Polato, F., Gunn, A., Bothmer, A., Feldhahn, N., Fernandez-Capetillo, O., Cao, L., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.012 · Cited by 1,671
XRCC3 promotes homology-directed repair of DNA damage in mammalian cellsPreprint
Pierce, A. J., Johnson, R. D., Thompson, L. H., & Jasin, M. (1999) · Genes & Development · doi:10.1101/gad.13.20.2633 · Cited by 1,384
Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W. (2003) · Science · doi:10.1126/science.1091362 · Cited by 804
Chromatin Challenges during DNA Replication and Repair
Groth, A., Rocha, W., Verreault, A., & Almouzni, G. (2007) · Cell · doi:10.1016/j.cell.2007.01.030 · Cited by 733
Flagged first, then by citations
1 of the 65 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Ubiquitin–proteasome system (UPS) as a target for anticancer treatment
Park, J., Cho, J., & Song, E. J. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01281-8 · Cited by 430
Zhang, H., Deng, T., Ge, S., Liu, Y., Bai, M., Zhu, K., Fan, Q., Li, J., Ning, T., Tian, F., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0619-z · Cited by 303
RetractedChen, S., Zhu, S., Pei, X., Qiu, B., Xiong, D., Long, X., Lin, K., Lü, F., Xu, J., & Wu, Y. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01448-x · Cited by 263
Discovery and characterization of highly potent and selective allosteric USP7 inhibitors
Gavory, G., O'Dowd, C. R., Helm, M. D., Flasz, J., Arkoudis, E., Dossang, A., Hughes, C., Cassidy, E., McClelland, K., Odrzywol, E., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2528 · Cited by 224
2-Oxoglutarate-dependent dioxygenases in cancer
Losman, J.-A., Koivunen, P., & Kaelin, W. G. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-00303-3 · Cited by 241
Structure-guided development of a potent and selective non-covalent active-site inhibitor of USP7.
Lamberto, I., Liu, X., Seo, H.-S., Schauer, N. J., Iacob, R. E., Hu, W., Das, D., Mikhailova, T., Weisberg, E. L., Engen, J. R., et al. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.09.003 · Cited by 192
Self-citationUSP7: Structure, substrate specificity, and inhibition
Pozhidaeva, A., & Bezsonova, I. (2019) · DNA Repair · doi:10.1016/j.dnarep.2019.02.005 · Cited by 178
“The enzyme is also overexpressed in breast carcinomas (14), as well as in lung squamous cell carcinoma and large cell carcinoma (15).”
BackgroundInfluentialEmerging insights into HAUSP (USP7) in physiology, cancer and other diseases.
Bhattacharya, S., Chakraborty, D., Basu, M., & Ghosh, M. K. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0012-y · Cited by 162
Qi, S., Cheng, G., Cheng, X., Xu, Z., Xu, B., Zhang, W., & Qin, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00233 · Cited by 167
Gao, H., Yin, J., Ji, C., Yu, X., Xue, J., Guan, X., Zhang, S., Liu, X., & Xing, F. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02805-y · Cited by 135
Self-citationUSP7: Novel Drug Target in Cancer Therapy
Wang, Z., Kang, W.-T., You, Y., Pang, J., Ren, H., Suo, Z., Liu, H., & Zheng, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00427 · Cited by 131
Arginine methylation‐dependent LSD1 stability promotes invasion and metastasis of breast cancer
Liu, J., Feng, J., Li, L., Lin, L., Ji, J., Lin, C., Liu, L., Zhang, N., Duan, D., Li, Z., et al. (2019) · EMBO Reports · doi:10.15252/embr.201948597 · Cited by 124
Self-citationUSP7 Is a Master Regulator of Genome Stability
Valles, G. J., Bezsonova, I., Woodgate, R., & Ashton, N. W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00717 · Cited by 114
“XPC is polyubiquitinated in cells in response to UV-induced DNA damage by a complex containing the DDB1-XPE proteins and the Cul4A E3 ubiquitin ligase (Sugasawa et al., 2005; Wang et al., 2005).”
BackgroundUbiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis
Su, D., Ma, S., Shan, L., Wang, Y., Wang, Y., Cao, C., Liu, B., Yang, C., Wang, L., Tian, S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120518 · Cited by 118
Self-citationCaron, P., Pankotai, T., Wiegant, W. W., Tollenaere, M. A. X., Furst, A., Bonhomme, C., Helfricht, A., de Groot, A., Pastink, A., Vertegaal, A. C. O., et al. (2019) · Genes & Development · doi:10.1101/gad.321943.118 · Cited by 110
Modulation of the p53/MDM2 interplay by HAUSP inhibitors
Tavana, O., & Gu, W. J. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw049 · Cited by 110
Deubiquitylating Enzymes in Cancer and Immunity
Ren, J., Yu, P., Liu, S., Li, R., Niu, X., Chen, Y., Zhang, Z., Zhou, F., & Zhang, L. (2023) · Advanced Science · doi:10.1002/advs.202303807 · Cited by 118
Xia, X., Liao, Y., Huang, C., Liu, Y., He, J., Shao, Z., Jiang, L., Dou, Q. P., Liu, J., & Huang, H. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.09.003 · Cited by 97
Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes
Cruz, L. L., Soares, P., & Correia, M. (2021) · Pharmaceuticals · doi:10.3390/ph14090848 · Cited by 98
Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma
Franqui-Machin, R., Hao, M., Bai, H., Gu, Z., Zhan, X., Habelhah, H., Jethava, Y. S., Qiu, L., Frech, I., Tricot, G. J. K., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98765 · Cited by 93
Chaturvedi, S. S., Ramanan, R., Lehnert, N., Schofield, C. J., Karabencheva‐Christova, T. G., & Christov, C. Z. (2019) · ACS Catalysis · doi:10.1021/acscatal.9b04907 · Cited by 91
Li, X., Kong, L., Yang, Q., Duan, A., Ju, X., Cai, B., Chen, L., An, T., & Li, Y. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011396 · Cited by 92
Self-citationThe emerging nature of Ubiquitin-specific protease 7 (USP7): a new target in cancer therapy
Nininahazwe, L., Liu, B., He, C., Zhang, H., & Chen, Z. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.028 · Cited by 94
He, L., Liu, X., Yang, J., Li, W., Liu, S., Liu, X., Yang, Z., Ren, J., Wang, Y., Shan, L., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0079-6 · Cited by 91
Self-citationGao, H., Xi, Z., Dai, J., Xue, J., Guan, X., Zhao, L., Chen, Z., & Xing, F. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02005-y · Cited by 81
Histone demethylase PHF8 promotes epithelial to mesenchymal transition and breast tumorigenesis
Shao, P., Liu, Q., Maina, P. K., Cui, J., Bair, T., Li, T., Umesalma, S., Zhang, W., & Qi, H. H. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1093 · Cited by 75
Pinto-Fernández, A., & Kessler, B. M. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00133 · Cited by 73
Functional analysis of deubiquitylating enzymes in tumorigenesis and development
Cheng, J., Guo, J., North, B. J., Wang, B., Cui, C., Li, H., Tao, K., Zhang, L., & Wei, W. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.188312 · Cited by 75
Identification and structure-guided development of pyrimidinone based USP7 inhibitors
O’Dowd, C. R., Helm, M. D., Rountree, J. S. S., Flasz, J. T., Arkoudis, E., Miel, H., Hewitt, P. R., Jordan, L., Barker, O., Hughes, C., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00512 · Cited by 71
USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia
Shan, H., Li, X., Xiao, X., Dai, Y., Huang, J., Song, J., Liu, M., Yang, L., Lei, H., Tong, Y., et al. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0028-3 · Cited by 66
Self-citationHighlights in USP7 inhibitors for cancer treatment
Oliveira, R. I., Guedes, R. A., & Salvador, J. A. R. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.1005727 · Cited by 64
Discovery of a Potent and Selective Degrader for USP7
Pei, Y., Fu, J., Shi, Y., Zhang, M., Luo, G., Luo, X., Song, N., Mi, T., Yang, Y., Li, J. X., et al. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202204395 · Cited by 68
Self-citationJMJD5 cleaves monomethylated histone H3 N‐tail under DNA damaging stress
Shen, J., Xiang, X., Chen, L., Wang, H., Wu, L., Sun, Y., Ma, L., Gu, X., Liu, H., Wang, L., et al. (2017) · EMBO Reports · doi:10.15252/embr.201743892 · Cited by 63
Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer
Suriyamurthy, S., Baker, D. A., ten Dijke, P., & Iyengar, P. V. (2019) · Cancers · doi:10.3390/cancers11050726 · Cited by 63
Hernández-Pérez, S., Cabrera, E., Salido, E., Lim, M., Reid, L., Lakhani, S. R., Khanna, K. K., Saunus, J. M., & Freire, R. (2017) · Oncogene · doi:10.1038/onc.2017.21 · Cited by 61
The HIF/PHF8/AR axis promotes prostate cancer progression
Tong, D., Liu, Q., Liu, G., Yuan, W., Wang, L., Guo, Y., Lan, W., Zhang, D., Dong, S., Wang, Y., et al. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.74 · Cited by 60
Self-citationLiu, Q., Pang, J., Wang, L.-A., Huang, Z., Xu, J., Yang, X., Xie, Q., Huang, Y., Tang, T., Tong, D., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5557 · Cited by 59
Targeting Ubiquitin-Specific Protease 7 (USP7) in Cancer: A New Insight to Overcome Drug Resistance
Lu, J., Zhao, H., Yu, C., Kang, Y., & Yang, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.648491 · Cited by 62
Epigenetic Dysregulations in Merkel Cell Polyomavirus-Driven Merkel Cell Carcinoma
Rotondo, J. C., Mazziotta, C., Lanzillotti, C., Tognon, M. G., & Martini, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111464 · Cited by 59
Dual-utility NLS drives RNF169-dependent DNA damage responses
An, L., Jiang, Y., Ng, H. H. W., Man, E. P. S., Chen, J., Khoo, U., Gong, Q., & Huen, M. S. Y. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616602114 · Cited by 61
The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival
He, Y., Wang, S., Tong, J., Jiang, S., Yang, Y., Zhang, Z., Xu, Y., Zeng, Y., Cao, B., Moran, M. F., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010724 · Cited by 55
Nuclear deubiquitination in the spotlight: the multifaceted nature of USP7 biology in disease
Rawat, R., Starczynowski, D. T., & Ntziachristos, P. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.02.008 · Cited by 54
Tang, Y., Lv, L., Li, W., Zhang, X., Jiang, Y., Ge, W., & Zhou, Y. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0637-8 · Cited by 56
Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy
Lai, K. P., Chen, J., & Tse, W. K. F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072548 · Cited by 52
20 years of histone lysine demethylases: From discovery to the clinic and beyond
Gray, Z. H., Honer, M. A., Ghatalia, P., Shi, Y., & Whetstine, J. R. (2025) · Cell · doi:10.1016/j.cell.2025.02.023 · Cited by 59
Zhou, W., Gong, L., Wu, Q., Xing, C., Wei, B., Chen, T., Zhou, Y., Yin, S., Jiang, B., Xie, H., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0890-4 · Cited by 50
The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression
Xia, X., Huang, C., Liao, Y., Liu, Y., He, J., Shao, Z., Hu, T., Yu, C., Jiang, L., Liu, J., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03607-w · Cited by 47
Peng, X., Zhang, S., Wang, Y., Zhou, Z., Yu, Z., Zhong, Z., Zhang, L., Chen, Z., Claret, F. X., Elkabets, M., et al. (2022) · Advanced Science · doi:10.1002/advs.202205529 · Cited by 48
Self-citationWu, J., Kumar, S., Wang, F., Wang, H., Chen, L., Arsenault, P., Mattern, M. R., & Weinstock, J. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00498 · Cited by 47
Jing, B., Liu, M., Yang, L. C., Cai, H., Chen, J., Li, Z.-X., Kou, X., Wu, Y., Qin, D., Zhou, L., et al. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.119 · Cited by 45
The Role of Histone Post-Translational Modifications in Merkel Cell Carcinoma
Mazziotta, C., Lanzillotti, C., Gafà, R., Touzé, A., Durand, M.-A., Martini, F., & Rotondo, J. C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.832047 · Cited by 44
USP7 deubiquitinates KRAS and promotes non-small cell lung cancer
Huang, B., Cao, D., Yuan, X., Xiong, Y., Chen, B., Wang, Y., Niu, X., Tian, R., & Huang, H. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114917 · Cited by 47
Self-citationThe emerging role of ubiquitin-specific protease 20 in tumorigenesis and cancer therapeutics
Li, Q., Ye, C., Tian, T., Jiang, Q., Zhao, P., Wang, X., Liu, F., Shan, J., & Ruan, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04853-2 · Cited by 44
Targeting Histone Modifications in Breast Cancer: A Precise Weapon on the Way
Li, W., Wu, H., Sui, S., Wang, Q., Xu, S., & Pang, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.736935 · Cited by 42
Self-citationChaturvedi, S. S., Rifayee, S. B. J. S., Waheed, S. O., Wildey, J., Warner, C., Schofield, C. J., Karabencheva‐Christova, T. G., & Christov, C. Z. (2022) · JACS Au · doi:10.1021/jacsau.2c00345 · Cited by 42
Saha, G., Sarkar, S., Mohanta, P. S., Kumar, K., Chakrabarti, S., Basu, M., & Ghosh, M. K. (2022) · Oncogene · doi:10.1038/s41388-022-02486-5 · Cited by 41
The nuclear phosphoinositide response to stress
Chen, M., Wen, T., Horn, H. T., Chandrahas, V. K., Thapa, N., Choi, S., Cryns, V. L., & Anderson, R. A. (2020) · Cell Cycle · doi:10.1080/15384101.2019.1711316 · Cited by 39
USP49 participates in the DNA damage response by forming a positive feedback loop with p53
Tu, R., Kang, W., Yang, X.-F., Zhang, Q., Xie, X., Liu, W., Zhang, J., Zhang, X.-D., Wang, H., & Du, R. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0475-3 · Cited by 41
Self-citationZeng, Q., Li, Z., Zhao, X., Guo, L., Yu, C., Qin, J., Zhang, S., Zhang, Y., & Yang, X. (2018) · Oncology Reports · doi:10.3892/or.2018.6835 · Cited by 40
Zhou, W., Gong, L., Wu, Q., Xing, C., Wei, B., Chen, T., Zhou, Y. M., Yin, S., Jiang, B., Xie, H., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0944-7 · Cited by 39
Lin, Y., Lin, J., Liu, Y.-E., Chen, Y.-C., Liu, S.-T., Hsu, K., Chen, D., & Wu, H.-T. (2022) · Cells · doi:10.3390/cells11203294 · Cited by 40
Lv, Y., Shi, Y. X., Han, Q., & Dai, G. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7130 · Cited by 37
Targeting ubiquitin specific protease 7 in cancer: A deubiquitinase with great prospects
Khusbu, F. Y., Chen, F., & Chen, H. (2018) · Cell Biochemistry and Function · doi:10.1002/cbf.3336 · Cited by 36
USP7 Regulates Cytokinesis through FBXO38 and KIF20B
Georges, A. A., Coyaud, É., Marcon, E., Greenblatt, J. F., Raught, B., & Frappier, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-39368-y · Cited by 42
Regulation of Histone Ubiquitination in Response to DNA Double Strand Breaks
Aquila, L., & Atanassov, B. S. (2020) · Cells · doi:10.3390/cells9071699 · Cited by 38
Deubiquitinating Enzymes and Bone Remodeling
Guo, Y., Zhang, S., & Yuan, Q. (2018) · Stem Cells International · doi:10.1155/2018/3712083 · Cited by 35
PHF8-GLUL axis in lipid deposition and tumor growth of clear cell renal cell carcinoma
Peng, S., Wang, Z., Tang, P., Wang, S., Huang, Y., Xie, Q., Wang, Y., Tan, X., Tang, T., Yan, X., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf3566 · Cited by 38
Self-citationEmerging role of ubiquitination/deubiquitination modification of PD-1/PD-L1 in cancer immunotherapy
Ding, P., Ma, Z., Fan, Y., Feng, Y., Shao, C., Pan, M., Zhang, Y., Huang, D., Han, J. Y., Hu, Y., et al. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.01.002 · Cited by 37
Structure-function relationships in KDM7 histone demethylases
Chaturvedi, S. S., Ramanan, R., Waheed, S. O., Karabencheva‐Christova, T. G., & Christov, C. Z. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.08.005 · Cited by 33
USP7 manipulation by viral proteins
Bojagora, A., & Saridakis, V. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198076 · Cited by 37
Chong, W., Zhang, H., Guo, Z., Yang, L., Shao, Y., Liu, X., Zhao, Y., Wang, Z., Zhang, M., Guo, C., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00607-9 · Cited by 32
Self-citationThe deubiquitinase USP7 promotes HNSCC progression via deubiquitinating and stabilizing TAZ
Li, J., Dai, Y., Ge, H., Guo, S., Zhang, W., Wang, Y., Liu, L., Cheng, J., & Jiang, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05113-z · Cited by 34
Self-citationLoss of PHF8 induces a viral mimicry response by activating endogenous retrotransposons
Liu, Y., Hu, L., Wu, Z., Yuan, K., Hong, G., Lian, Z., Feng, J., Li, N., Li, D., Wong, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39943-y · Cited by 32
The histone demethylase PHF8 regulates TGFβ signaling and promotes melanoma metastasis
Moubarak, R. S., de Pablos-Aragoneses, A., Ortiz-Barahona, V., Gong, Y., Gowen, M. F., Dolgalev, I., Shadaloey, S. A. A., Argibay, D., Karz, A., Itter, R. V., et al. (2022) · Science Advances · doi:10.1126/sciadv.abi7127 · Cited by 30
PHF8 Plays an Oncogene Function in Hepatocellular Carcinoma Formation
Ye, H., Yang, Q. F., Qi, S., & Li, H. (2019) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15410353669149 · Cited by 30
Sun, Y., Cao, L., Sheng, X., Chen, J., Zhou, Y., Yang, C., Deng, T., Ma, H., Feng, P., Liu, J., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.162 · Cited by 31
Tang, X., Xiao, Q., & Yu, K. (2020) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2020.2990178 · Cited by 30
Liu, Q., Borcherding, N. C., Shao, P., Maina, P. K., Zhang, W., & Qi, H. H. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.102612 · Cited by 30
Bimodal regulation of the PRC2 complex by USP7 underlies tumorigenesis
Su, D., Wang, W., Hou, Y., Wang, L., Yi, X., Cao, C., Wang, Y., Gao, H. F., Wang, Y., Yang, C., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab209 · Cited by 34
Self-citationCapasso, M., Lasorsa, V. A., Cimmino, F., Avitabile, M., Cantalupo, S., Montella, A., Angelis, B. D., Morini, M., de Torres, C., Castellano, A., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-2883 · Cited by 29
Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance
Shin, S., Kim, C.-H., Jang, H.-R., & Yim, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228629 · Cited by 28
Conformational Dynamics Underlies Different Functions of Human KDM7 Histone Demethylases
Chaturvedi, S. S., Ramanan, R., Waheed, S. O., Ainsley, J., Evison, M., Ames, J. M., Schofield, C. J., Karabencheva‐Christova, T. G., & Christov, C. Z. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201900492 · Cited by 28
Design and Construction of a Focused DNA-Encoded Library for Multivalent Chromatin Reader Proteins
Rectenwald, J. M., Guduru, S. K. R., Dang, Z., Collins, L. B., Liao, Y.-E., Norris-Drouin, J. L., Cholensky, S. H., Kaufmann, K. W., Hammond, S. M., Kireev, D., et al. (2020) · Molecules · doi:10.3390/molecules25040979 · Cited by 27
PHF8-promoted TOPBP1 demethylation drives ATR activation and preserves genome stability
Ma, S., Cao, C., Che, S., Wang, Y., Su, D., Liu, S., Gong, W., Liu, L., Sun, J., Zhao, J., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf7684 · Cited by 29
Self-citationHuang, M., Shen, G.-T., & Li, N. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i32.11690 · Cited by 27
Xiang, M., Liang, L., Kuang, X., Xie, Z., Liu, J., Zhao, S., Su, J., Chen, X., & Liu, H. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16834 · Cited by 27
Srivastava, M., Mittal, L., Kumari, A., Agrahari, A. K., Singh, M., Mathur, R., & Asthana, S. (2022) · Protein Science · doi:10.1002/pro.4398 · Cited by 27
Zhou, L., Ouyang, T., Li, M., Hong, T., Alriashy, M. H. S., Meng, W., & Zhang, N. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.784672 · Cited by 24
Ubiquitin-specific proteases: Vital regulatory molecules in bone and bone-related diseases
Luo, W., Zhang, G., Wang, Z., Wu, Y., & Xiong, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110075 · Cited by 25
USP7 substrates identified by proteomics analysis reveal the specificity of USP7Preprint
Nie, L., Wang, C., Liu, X., Teng, H., Li, S., Huang, M., Feng, X., Pei, G., Hang, Q., Zhao, Z., et al. (2022) · Genes & Development · doi:10.1101/gad.349848.122 · Cited by 24
Self-citationSong, Y., Ren, X., Xiong, J., Wang, W., Zhao, Q., Chang, J., & Yu, B. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00102 · Cited by 22
McCann, T. S., Sobral, L. M., Self, C., Hsieh, J. C. Y., Sechler, M., & Jedlicka, P. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1580692 · Cited by 21
Liu, J., Cao, L., Wang, Y., Zou, Y. F., Guo, Q., Chen, S., Jiang, B., Wu, X., Zheng, L., Zhang, S., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114366 · Cited by 20
Self-citationJiang, Y., Ni, S., Xiao, B., & Jia, L. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.07.019 · Cited by 22
The emerging roles of histone demethylases in cancers
Tong, D., Tang, Y., & Zhong, P. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10160-9 · Cited by 20
Histone demethylase PHF8 regulates hypoxia signaling through HIF1α and H3K4me3
Maina, P. K., Shao, P., Jia, X., Liu, Q., Umesalma, S., Marin, M. J., Long, D., Concepción-Román, S., & Qi, H. H. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.07.005 · Cited by 19
Fu, Y., Yang, Y., Wang, X., Yin, X., Zhou, M., Wang, S., Yang, L. S., Huang, T., Xu, M., & Chen, C. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.049 · Cited by 20
USP7 stabilizes EZH2 and enhances cancer malignant progression.
Zheng, N., Chu, M., Lin, M., He, Y., & Wang, Z. P. (2020) · PubMed · Cited by 20
USP7 deubiquitinates and stabilizes SIRT1.
Song, N., Cao, C., Tian, S., Long, M., & Liu, L. (2020) · The Anatomical Record · doi:10.1002/ar.24252 · Cited by 19
Self-citationUSP7 controls NGN3 stability and pancreatic endocrine lineage development
Manea, T., Nelson, J. K., Garrone, C. M., Hansson, K., Evans, I. M., Behrens, A., & Sancho, R. (2023) · Nature Communications · doi:10.1038/s41467-023-38146-9 · Cited by 20
Metadata
- Authors
- Wang, Q., Ma, S., Song, N., Li, X., Liu, L., Yang, S., Ding, X., Shan, L., Zhou, X., Su, D., Wang, Y., Zhang, Q., Liu, X., Yu, N., Zhang, K., Shang, Y., Yao, Z., & Shi, L.
- Affiliations
- Tianjin Medical University (CN)
- Chinese Academy of Sciences (CN)
- Peking University (CN)
- Corresponding author
- Yao, Zhi
- Shi, Lei
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2016-05-16
- Volume
- 126
- Issue
- 6
- Pages
- 2205-2220
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC4887182
- OpenAlex
- W2381681988
- Cited by
- 206
- References
- 65
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 25 · 2023: 19 · 2022: 23 · 2021: 17 · 2020: 30 · 2019: 24 · 2018: 16 · 2017: 18 · 2016: 5
- FWCI
- 10.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tianjin Medical University
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- PHF8, USP7, histone demethylase, protein stabilization, deubiquitination, breast cancer, cyclin A2, DNA double-strand break repair, BLM, Ku70, DNA damage response, epigenetic regulation, positive feedback loop, histone demethylation
- MeSH terms
- Ubiquitin-Specific Peptidase 7, Breast Neoplasms, DNA Damage, DNA Repair, Enzyme Stability, Female, Humans, Transcription Factors, Up-Regulation, RNA, Small Interfering, Ubiquitin Thiolesterase, Epigenesis, Genetic, Protein Interaction Domains and Motifs, Histone Demethylases, Cyclin A2, MCF-7 Cells, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
